The Scientist

» pharma and microbiology

Most Recent

image: Exploring the Inner Universe

Exploring the Inner Universe

By | November 6, 2015

A new American Museum of Natural History exhibit introduces visitors to the microbes within their bodies. 

0 Comments

image: Shire Buys Rare Disease Drug Developer

Shire Buys Rare Disease Drug Developer

By | November 2, 2015

The Irish drugmaker is set to acquire the Massachusetts-based Dyax in a $5.9 billion deal.

0 Comments

image: Capsule Reviews

Capsule Reviews

By | November 1, 2015

The Psychology of Overeating, The Hidden Half of Nature, The Death of Cancer, and The Secret of Our Success

0 Comments

image: Microbesity

Microbesity

By | November 1, 2015

Obesity appears linked to the gut microbiome. How and why is still a mystery—but scientists have plenty of ideas.

2 Comments

image: Daraprim Alternative

Daraprim Alternative

By | October 22, 2015

A specialty pharmaceuticals company announces plans to produce a toxoplasmosis drug containing the same active ingredient as the pill at the center of an ongoing drug-pricing controversy.

1 Comment

image: Microbiome Meals

Microbiome Meals

By | October 1, 2015

Researchers identify a handful of genes that help bacteria in the mouse gut adapt to dietary changes.

0 Comments

image: Gut Bacteria Linked to Asthma Risk

Gut Bacteria Linked to Asthma Risk

By | October 1, 2015

Four types of gut bacteria found in babies’ stool may help researchers predict the future development of asthma.

0 Comments

image: Cultural Riches

Cultural Riches

By | October 1, 2015

Researchers devise new techniques to facilitate growing bacteria collected from the environment.

0 Comments

image: Lost Colonies

Lost Colonies

By | October 1, 2015

Next-generation sequencing has identified scores of new microorganisms, but getting even abundant bacterial species to grow in the lab has proven challenging.

0 Comments

image: Biotech Stocks Take a Hit

Biotech Stocks Take a Hit

By | September 30, 2015

Some say the biotech bubble has burst over concerns that drug prices are too high—and may soon be regulated.

1 Comment

Popular Now

  1. Broad Wins CRISPR Patent Interference Case
    Daily News Broad Wins CRISPR Patent Interference Case

    The USPTO’s Patent Trial and Appeal Board has ruled in favor of the Broad Institute of MIT and Harvard retaining intellectual property rights covered by its patents for CRISPR gene-editing technology.

  2. Henrietta Lacks’s Family Seeks Compensation
  3. Can Plants Learn to Associate Stimuli with Reward?
  4. Humans Never Stopped Evolving
    Features Humans Never Stopped Evolving

    The emergence of blood abnormalities, an adult ability to digest milk, and changes in our physical appearance point to the continued evolution of the human race.

Business Birmingham